Who owns Generate Biomedicines, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GENB from SEC Form 13F filings across 109 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 109 institutions disclosed 106.7M shares of Generate Biomedicines, Inc. worth $1.60B — about 83.1% of shares outstanding; the largest disclosed holder is Flagship Pioneering, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
109
13F holders
$1.60B
value, 2026 filers
83.1%
of shares outstanding (106.7M sh)
35
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of GENB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Flagship Pioneering, LLC | 62.7M | $941.4M | 48.1% | 48.8% | 0.0% |
| 2 | FMR LLC | 7.2M | $107.9M | 0.0% | 5.6% | +37.6% |
| 3 | Capital World Investors | 4.2M | $63.1M | 0.0% | 3.3% | -0.3% |
| 4 | BRAIDWELL LP | 3.0M | $44.5M | 1.8% | 2.3% | -9.8% |
| 5 | JPMORGAN CHASE & CO | 2.7M | $40.9M | 0.0% | 2.1% | +88.3% |
| 6 | Deep Track Capital, LP | 2.5M | $37.7M | 0.6% | 2% | +88.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $33.6M | 0.0% | 1.7% | +97.4% |
| 8 | ARK Investment Management LLC | 2.0M | $29.5M | 0.2% | 1.5% | +52.9% |
| 9 | ARCH Venture Management, LLC | 1.9M | $29.2M | 1.8% | 1.5% | 0.0% |
| 10 | BlackRock, Inc. | 1.8M | $27.5M | 0.0% | 1.4% | +10.3% |
| 11 | BANQUE PICTET & CIE SANEW | 1.8M | $26.6M | 0.2% | 1.4% | new |
| 12 | HarbourVest Partners LLC | 1.7M | $25.9M | 16.7% | 1.3% | 0.0% |
| 13 | BAKER BROS. ADVISORS LP | 1.4M | $21.4M | 0.1% | 1.1% | 0.0% |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.3M | $20.1M | 0.0% | 1% | -38.0% |
| 15 | ArrowMark Colorado Holdings LLCNEW | 1.1M | $16.7M | 0.8% | 0.9% | new |
| 16 | NVIDIA CORP | 833,325 | $12.5M | 0.0% | 0.6% | 0.0% |
| 17 | Davern Capital Partners, LP | 824,679 | $12.4M | 2.4% | 0.6% | 0.0% |
| 18 | Siren, L.L.C. | 736,104 | $11.1M | 0.3% | 0.6% | 0.0% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 729,083 | $11.0M | 0.0% | 0.6% | -0.8% |
| 20 | STATE STREET CORP | 546,337 | $8.2M | 0.0% | 0.4% | +3.8% |
| 21 | MILLENNIUM MANAGEMENT LLC | 541,886 | $8.1M | 0.0% | 0.4% | +2371.4% |
| 22 | MORGAN STANLEY | 522,410 | $7.8M | 0.0% | 0.4% | +38.2% |
| 23 | VOLORIDGE INVESTMENT MANAGEMENT, LLCNEW | 362,138 | $5.4M | 0.0% | 0.3% | new |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 237,416 | $3.6M | 0.0% | 0.2% | +5.7% |
| 25 | TWO SIGMA INVESTMENTS, LP | 205,195 | $3.1M | 0.0% | 0.2% | +1016.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.